Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Lymphomes non hodgkinien
- | Specialty :
- Chimiothérapie
Extract
A Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid®) in Subjects With Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma.
Scientific Abstract
en cours d'intégration;